The analgesic medicine sales in Spain stood at 30.12 USD PPP per capita in 2023. Moving forward, the forecast anticipates steady growth: 31 USD in 2024, 31.85 USD in 2025, 32.69 USD in 2026, and 33.51 USD in 2027.
Year-on-year variation indicates:
- From 2023 to 2024: 2.9% increase
- From 2024 to 2025: 2.7% increase
- From 2025 to 2026: 2.6% increase
- From 2026 to 2027: 2.5% increase
The Compound Annual Growth Rate (CAGR) for the 2023-2027 period is approximately 2.7%.
Future trends to watch for include advancements in medicinal technology, changes in healthcare policies, and demographic shifts impacting demand for analgesics. It will also be crucial to monitor the impacts of economic conditions on PPP calculations and consumer purchasing power.
